These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 10650131
1. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Storch A, Kaftan A, Burkhardt K, Schwarz J. Brain Res; 2000 Feb 07; 855(1):67-75. PubMed ID: 10650131 [Abstract] [Full Text] [Related]
2. 6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism. Storch A, Kaftan A, Burkhardt K, Schwarz J. J Neural Transm (Vienna); 2000 Feb 07; 107(3):281-93. PubMed ID: 10821437 [Abstract] [Full Text] [Related]
3. Studies on the neurotoxicity of 6,7-dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline (salsolinol) in SH-SY5Y cells. Willets JM, Lambert DG, Lunec J, Griffiths HR. Eur J Pharmacol; 1995 Dec 07; 293(4):319-26. PubMed ID: 8748684 [Abstract] [Full Text] [Related]
5. Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). McNaught KS, Thull U, Carrupt PA, Altomare C, Cellamare S, Carotti A, Testa B, Jenner P, Marsden CD. Biochem Pharmacol; 1995 Nov 27; 50(11):1903-11. PubMed ID: 8615871 [Abstract] [Full Text] [Related]
6. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism. Lannuzel A, Michel PP, Höglinger GU, Champy P, Jousset A, Medja F, Lombès A, Darios F, Gleye C, Laurens A, Hocquemiller R, Hirsch EC, Ruberg M. Neuroscience; 2003 Nov 27; 121(2):287-96. PubMed ID: 14521988 [Abstract] [Full Text] [Related]
7. Effects of enhancing mitochondrial oxidative phosphorylation with reducing equivalents and ubiquinone on 1-methyl-4-phenylpyridinium toxicity and complex I-IV damage in neuroblastoma cells. Mazzio EA, Soliman KF. Biochem Pharmacol; 2004 Mar 15; 67(6):1167-84. PubMed ID: 15006552 [Abstract] [Full Text] [Related]
8. Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease. Höglinger GU, Carrard G, Michel PP, Medja F, Lombès A, Ruberg M, Friguet B, Hirsch EC. J Neurochem; 2003 Sep 15; 86(5):1297-307. PubMed ID: 12911637 [Abstract] [Full Text] [Related]
9. Uncoupling of ATP-depletion and cell death in human dopaminergic neurons. Pöltl D, Schildknecht S, Karreman C, Leist M. Neurotoxicology; 2012 Aug 15; 33(4):769-79. PubMed ID: 22206971 [Abstract] [Full Text] [Related]
10. Salsolinol Protects SH-SY5Y Cells Against MPP+ Damage and Increases Enteric S100-Immunoreactivity in Wistar Rats. Kurnik-Łucka M, Latacz G, Goryl J, Aleksandrovych V, Gil K. Neurochem Res; 2023 May 15; 48(5):1347-1359. PubMed ID: 36449199 [Abstract] [Full Text] [Related]
11. MPP(+) causes inhibition of cellular energy supply in cerebellar granule cells. González-Polo RA, Soler G, Alonso JC, Rodríguez-Martín A, Fuentes JM. Neurotoxicology; 2003 Mar 15; 24(2):219-25. PubMed ID: 12606294 [Abstract] [Full Text] [Related]
12. Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines. Naoi M, Maruyama W, Kasamatsu T, Dostert P. J Neural Transm Suppl; 1998 Mar 15; 52():125-38. PubMed ID: 9564615 [Abstract] [Full Text] [Related]
13. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration. Suzuki K, Mizuno Y, Yoshida M. Adv Neurol; 1990 Mar 15; 53():215-8. PubMed ID: 2122645 [Abstract] [Full Text] [Related]
14. Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N-methyl-4-phenylpyridinium (MPP+) towards cultured dopaminergic neuroblastoma cells. Fang J, Zuo D, Yu PH. Psychopharmacology (Berl); 1995 Oct 15; 121(3):373-8. PubMed ID: 8584620 [Abstract] [Full Text] [Related]
15. The inhibition site of MPP+, the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is near the Q-binding site of NADH dehydrogenase. Ramsay RR, Kowal AT, Johnson MK, Salach JI, Singer TP. Arch Biochem Biophys; 1987 Dec 15; 259(2):645-9. PubMed ID: 2827583 [Abstract] [Full Text] [Related]
16. TRPC1 protects dopaminergic SH-SY5Y cells from MPP+, salsolinol, and N-methyl-(R)-salsolinol-induced cytotoxicity. Arshad A, Chen X, Cong Z, Qing H, Deng Y. Acta Biochim Biophys Sin (Shanghai); 2014 Jan 15; 46(1):22-30. PubMed ID: 24252728 [Abstract] [Full Text] [Related]
17. Protective effects of riluzole on dopamine neurons: involvement of oxidative stress and cellular energy metabolism. Storch A, Burkhardt K, Ludolph AC, Schwarz J. J Neurochem; 2000 Dec 15; 75(6):2259-69. PubMed ID: 11080177 [Abstract] [Full Text] [Related]
18. TRPC1 protects human SH-SY5Y cells against salsolinol-induced cytotoxicity by inhibiting apoptosis. Bollimuntha S, Ebadi M, Singh BB. Brain Res; 2006 Jul 12; 1099(1):141-9. PubMed ID: 16765919 [Abstract] [Full Text] [Related]
19. Decreased expression of the NADH:ubiquinone oxidoreductase (complex I) subunit 4 in 1-methyl-4-phenylpyridinium -treated human neuroblastoma SH-SY5Y cells. Conn KJ, Ullman MD, Eisenhauer PB, Fine RE, Wells JM. Neurosci Lett; 2001 Jun 29; 306(3):145-8. PubMed ID: 11406316 [Abstract] [Full Text] [Related]
20. Dependence on electron transport chain function and intracellular signaling of genomic responses in SH-SY5Y cells to the mitochondrial neurotoxin MPP(+). Brill LB, Bennett JP. Exp Neurol; 2003 May 29; 181(1):25-38. PubMed ID: 12710931 [Abstract] [Full Text] [Related] Page: [Next] [New Search]